Snake bites

  • Etiology & Differentiation:
    • Pit Vipers (Crotalinae: rattlesnakes, copperheads, cottonmouths): 1–2 puncture fang marks, rapid local tissue edema/necrosis, hemorrhagic bullae, and consumptive coagulopathy.
    • Coral Snakes (Elapidae: “red on yellow, kill a fellow”): Minimal local findings; causes delayed (up to 12h) descending paralysis (ptosis, diplopia, dysarthria) and respiratory arrest.
  • Contraindicated Interventions (High-Yield):
    • DO NOT use tourniquets, arterial bands, ice/cryotherapy, incisions, or suction devices (worsens local tissue ischemia without removing venom). c
    • DO: Immobilize limb in a neutral position at heart level and transport immediately.
  • Diagnostic Workup & Monitoring:
    • Serial exams: Mark advancing edge of erythema/edema and measure limb circumference q15–30 min.
    • Serial labs (baseline and q2–4h): ↓ Fibrinogen (earliest/most sensitive marker), ↑ PT/INR, thrombocytopenia, and CK/Cr.
  • Acute Management:
    • Initial: ABCs, aggressive IVF resuscitation for shock, and tetanus toxoid update.
    • Antibiotics: NO prophylactic Abx indicated (wound infections are rare).
    • Pit Viper Antivenom (CroFab / Anavip): c
      • Indications: Rapidly advancing swelling (crosses a major joint), systemic signs (shock), or coagulopathy (platelets < 100k, fibrinogen < 100 mg/dL).
    • Coral Snake Antivenom:
      • Administer immediately if bite is confirmed, even if asymptomatic (neurotoxicity is irreversible once symptoms develop).
  • Surgical Decision-Making:
    • Suspected Compartment Syndrome: Most cases represent venom-induced subcutaneous edema; give additional antivenom first.
    • Fasciotomy: Indicated ONLY if intracompartmental pressure > 30 mmHg refractory to antivenom and correction of coagulopathy.
  • Disposition & Complications:
    • Observation: Minimum 8–12h for asymptomatic “dry” pit viper bites; 24h in ICU for coral snake bites.
    • Venom-Induced Consumptive Coagulopathy (VICC): Severe bleeding risk secondary to defibrination and thrombocytopenia.
    • Serum Sickness: Type III hypersensitivity reaction occurring 1–2 weeks post-antivenom (fever, urticaria, polyarthralgias); treat with oral corticosteroids.

Hymenoptera stings

  • Clinical Presentations:
    • Local Reaction: Minor erythema, edema (< 5 cm), sharp pain; resolves in hours.
    • Large Local Reaction (LLR): IgE-mediated contiguous swelling (> 10 cm) peaking at 24–48h; sterile inflammation often confused with cellulitis. c
    • Systemic (Anaphylaxis): Urticaria, angioedema, stridor/wheezing, GI cramps, hypotension/shock.
    • Toxic Envenomation (> 50–100 stings): Direct toxin load causing rhabdomyolysis, hemolysis, and ATN/AKI.
  • Diagnosis:
    • Acute: Purely clinical diagnosis; obtain serum tryptase only if diagnosis is ambiguous.
    • Post-Acute Workup: Venom-specific skin testing or venom-specific serum IgE.
      • Must be delayed ≥ 4–6 weeks post-sting to avoid false negatives (refractory anergic period).
      • Indicated only for patients with prior systemic/anaphylactic reactions (not for isolated local/LLRs).
  • Differential Highlights:
    • Cellulitis: Indolent onset (> 48–72h), fever, purulence, ascending lymphangitis (LLR is sterile and peaks early). c
    • Brown Recluse Spider: Necrotic ulcer with central violaceous blanching (“bull’s-eye” lesion).
    • Black Widow Spider: Dual puncture marks, severe muscle spasms, rigid “board-like” abdomen.
  • Acute Management:
    • 1st-Line (Life-Saving): IM Epinephrine (1:1000) in the anterolateral thigh (0.3–0.5 mg in adults; 0.01 mg/kg in kids); repeat q5–15min PRN.
    • Airway/Breathing: High-flow O2, early endotracheal intubation if stridor/hoarseness develops, inhaled albuterol for bronchospasm.
    • Circulation: Aggressive IVF boluses (1–2 L isotonic crystalloid) for hypotension; place patient supine/elevate legs.
    • Adjuncts (Never delay Epinephrine): IV H1/H2-blockers, systemic corticosteroids (reduce biphasic risk).
    • Refractory/Special Case: IV Glucagon for patients on beta-blockers with refractory hypotension.
    • Local/LLR Care: Scrape stinger, cold compresses, oral NSAIDs/antihistamines; short-course PO prednisone for severe LLR (no routine antibiotics).
  • Disposition & Long-Term Prevention:
    • Observation: Monitor in ED for 4–8 hours to rule out biphasic reactions.
    • Discharge: Prescribe two Epinephrine auto-injectors (EpiPens) and provide administration training.
    • Venom Immunotherapy (VIT):
      • Indicated for systemic anaphylaxis + positive skin/IgE test.
      • Reduces recurrent anaphylaxis risk from 30–60% down to < 5%.
      • Not indicated for isolated cutaneous reactions in children < 16 years or isolated LLRs.